Jeremy Clarkson is trying to lose some weight, and he tried to do that with Ozempic (a GLP-1 agonist; generic name Semaglutide).
That wasn’t a success, so he’s now trying another similar drug called Mounjaro (tirzepatide; which he playfully called “Muntjac” in his column, in The Times (on 30th March 2025):
- “When you are on Muntjac, you can come down in the morning and idly help yourself to a small handful of sunflower seeds. And it’ll feel like you’ve just finished a massive Christmas lunch. You’re stuffed.
- “So you find yourself living a minibar existence. Tiny packets of milk, sachets with only three grains of sugar in them, vodka in thimbles. That’s not living, though. That’s existing.”
He went on ..
- “Certainly, I was a bit peeved when my friends came round for Sunday lunch. I’m used to the women eating one bit of cress but can normally rely on the men to want another Yorkshire and maybe a few more roasties.
- However, it was as if they’d all arrived after a night in Pablo Escobar’s man cave. They didn’t eat a thing.
- And neither did I, which saddened me. Because making food and sharing it with your friends should be a joyful thing. And celery isn’t even on nodding terms with (the word) joyful.”
Did they work for him?
Ozempic made him sick. So thats a ‘no’ for that. He continued ..
- “Three months ago I started a course of the other one. Muntjac, I think it’s called. And this is better because even though I’m only microdosing at the moment, I can open the fridge, look at all the goodies in there and then close it.
- I haven’t lost any weight but it seems inevitable that, as I no longer want to eat my own body weight in chocolate and beef, I will.”
Time will tell. Let’s wait for his next update.
Other resources
This is the full version of this column on Clarkson, Ozempic and Muntjac.